BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26125249)

  • 1. Tuberculosis vaccine development: Shifting focus amid increasing development challenges.
    Graves AJ; Hokey DA
    Hum Vaccin Immunother; 2015; 11(8):1910-6. PubMed ID: 26125249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel multivalent tuberculosis vaccine confers protection in a mouse model of tuberculosis.
    Griffiths KL; Villarreal DO; Weiner DB; Khader SA
    Hum Vaccin Immunother; 2016 Oct; 12(10):2649-2653. PubMed ID: 27322875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MTBVAC from discovery to clinical trials in tuberculosis-endemic countries.
    Marinova D; Gonzalo-Asensio J; Aguilo N; Martin C
    Expert Rev Vaccines; 2017 Jun; 16(6):565-576. PubMed ID: 28447476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling the host immune response to tuberculosis vaccines.
    Fletcher HA
    Vaccine; 2015 Sep; 33(40):5313-5. PubMed ID: 26241949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current state of tuberculosis vaccines.
    Hokey DA; Ginsberg A
    Hum Vaccin Immunother; 2013 Oct; 9(10):2142-6. PubMed ID: 23792698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel tuberculosis vaccines on the horizon.
    Parida SK; Kaufmann SH
    Curr Opin Immunol; 2010 Jun; 22(3):374-84. PubMed ID: 20471231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why don't we have an effective tuberculosis vaccine yet?
    Davenne T; McShane H
    Expert Rev Vaccines; 2016 Aug; 15(8):1009-13. PubMed ID: 27010255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of clinical models for the evaluation of human TB vaccines.
    O'Shea MK; McShane H
    Hum Vaccin Immunother; 2016 May; 12(5):1177-87. PubMed ID: 26810964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In search of a new paradigm for protective immunity to TB.
    Nunes-Alves C; Booty MG; Carpenter SM; Jayaraman P; Rothchild AC; Behar SM
    Nat Rev Microbiol; 2014 Apr; 12(4):289-99. PubMed ID: 24590243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human biomarkers: can they help us to develop a new tuberculosis vaccine?
    Fletcher HA; Dockrell HM
    Future Microbiol; 2016 Jun; 11():781-7. PubMed ID: 27203133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and novel approaches to vaccine development against tuberculosis.
    Cayabyab MJ; Macovei L; Campos-Neto A
    Front Cell Infect Microbiol; 2012; 2():154. PubMed ID: 23230563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis vaccine development at a divide.
    Kaufmann SH
    Curr Opin Pulm Med; 2014 May; 20(3):294-300. PubMed ID: 24626237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TB vaccines for the World.
    Glyn Hewinson R
    Tuberculosis (Edinb); 2005; 85(1-2):1-6. PubMed ID: 15687020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of mutant mycobacteria as new vaccines to prevent tuberculosis.
    Hernàndez Pando R; Aguilar LD; Infante E; Cataldi A; Bigi F; Martin C; Gicquel B
    Tuberculosis (Edinb); 2006; 86(3-4):203-10. PubMed ID: 16542875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An adult zebrafish model for preclinical tuberculosis vaccine development.
    Oksanen KE; Halfpenny NJ; Sherwood E; Harjula SK; Hammarén MM; Ahava MJ; Pajula ET; Lahtinen MJ; Parikka M; Rämet M
    Vaccine; 2013 Oct; 31(45):5202-9. PubMed ID: 24055305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rational vaccine pipeline for tuberculosis.
    Brennan MJ; Stone MR; Evans T
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1566-73. PubMed ID: 23131253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A PE_PGRS33 protein of Mycobacterium tuberculosis: an ideal target for future tuberculosis vaccine design.
    Gastelum-Aviña P; Velazquez C; Espitia C; Lares-Villa F; Garibay-Escobar A
    Expert Rev Vaccines; 2015 May; 14(5):699-711. PubMed ID: 25693607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new TB vaccine: fact or fiction?
    van Helden PD; Hoal EG
    Comp Immunol Microbiol Infect Dis; 2013 May; 36(3):287-94. PubMed ID: 22921282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.